Company: HCWB
Filing Date: 2025-04-01
Form Type: 8-K
Source: 0000950170-25-048619
Chunk: 6

Company: HCW Biologics Inc.
Filing Date: 2025-04-01
Form: 8-K
Item: Item 9.01
Chunk 6
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

  Exhibit No.      Description                                                                                                      
  3.1a             Certificate of Amendment of Certificate of Incorporation, filed March 31, 2025.                                  
  3.1b             Certificate of Correction of the Certificate of Amendment of Certificate of Incorporation, filed April 1, 2025.  
  99.1             Press release, dated April 1, 2025, announcing reverse stock split.                                              
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  104              Cover Page Interactive Data File (embedded within the Inline XBRL document).                                     

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                                         HCW BIOLOGICS INC.                                 
  Date:      April 1, 2025      By:      /s/ Hing C. Wong                                   
                                         Hing C. Wong, Founder and Chief Executive Officer